These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 11409580)
1. The early bactericidal activity of amikacin in pulmonary tuberculosis. Donald PR; Sirgel FA; Venter A; Smit E; Parkin DP; Van de Wal BW; Mitchison DA Int J Tuberc Lung Dis; 2001 Jun; 5(6):533-8. PubMed ID: 11409580 [TBL] [Abstract][Full Text] [Related]
2. The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis. Chan SL; Yew WW; Ma WK; Girling DJ; Aber VR; Felmingham D; Allen BW; Mitchison DA Tuber Lung Dis; 1992 Feb; 73(1):33-8. PubMed ID: 1326348 [TBL] [Abstract][Full Text] [Related]
3. The early bactericidal activity of streptomycin. Donald PR; Sirgel FA; Venter A; Smit E; Parkin DP; Van de Wal BW; Doré CJ; Mitchison DA Int J Tuberc Lung Dis; 2002 Aug; 6(8):693-8. PubMed ID: 12150481 [TBL] [Abstract][Full Text] [Related]
4. Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis. Gillespie SH; Gosling RD; Uiso L; Sam NE; Kanduma EG; McHugh TD J Antimicrob Chemother; 2005 Dec; 56(6):1169-71. PubMed ID: 16223939 [TBL] [Abstract][Full Text] [Related]
5. The early bactericidal activity of anti-tuberculosis drugs: a literature review. Donald PR; Diacon AH Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S75-83. PubMed ID: 18762155 [TBL] [Abstract][Full Text] [Related]
6. Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients. Diacon AH; Dawson R; Hanekom M; Narunsky K; Venter A; Hittel N; Geiter LJ; Wells CD; Paccaly AJ; Donald PR Int J Tuberc Lung Dis; 2011 Jul; 15(7):949-54. PubMed ID: 21682970 [TBL] [Abstract][Full Text] [Related]
7. The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazid. Donald PR; Sirgel FA; Venter A; Parkin DP; Seifart HI; van de Wal BW; Werely C; van Helden PD; Maritz JS Clin Infect Dis; 2004 Nov; 39(10):1425-30. PubMed ID: 15546075 [TBL] [Abstract][Full Text] [Related]
8. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis. Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142 [TBL] [Abstract][Full Text] [Related]
9. The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis. Donald PR; Sirgel FA; Botha FJ; Seifart HI; Parkin DP; Vandenplas ML; Van de Wal BW; Maritz JS; Mitchison DA Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):895-900. PubMed ID: 9310010 [TBL] [Abstract][Full Text] [Related]
10. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears. Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
12. The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis. Gosling RD; Uiso LO; Sam NE; Bongard E; Kanduma EG; Nyindo M; Morris RW; Gillespie SH Am J Respir Crit Care Med; 2003 Dec; 168(11):1342-5. PubMed ID: 12917230 [TBL] [Abstract][Full Text] [Related]
13. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia. Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916 [TBL] [Abstract][Full Text] [Related]
14. Whole blood bactericidal activity during treatment of pulmonary tuberculosis. Wallis RS; Vinhas SA; Johnson JL; Ribeiro FC; Palaci M; Peres RL; Sá RT; Dietze R; Chiunda A; Eisenach K; Ellner JJ J Infect Dis; 2003 Jan; 187(2):270-8. PubMed ID: 12552451 [TBL] [Abstract][Full Text] [Related]
15. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis. Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC; Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516 [TBL] [Abstract][Full Text] [Related]
16. The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis. Sirgel FA; Botha FJ; Parkin DP; Van de Wal BW; Schall R; Donald PR; Mitchison DA Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):901-5. PubMed ID: 9310011 [TBL] [Abstract][Full Text] [Related]
17. Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation? Fortún J; Martín-Dávila P; Molina A; Navas E; Hermida JM; Cobo J; Gómez-Mampaso E; Moreno S J Antimicrob Chemother; 2007 Apr; 59(4):794-8. PubMed ID: 17392354 [TBL] [Abstract][Full Text] [Related]